$ATHA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Athira Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Athira Pharma, Inc.. Get notifications about new insider transactions in Athira Pharma, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
| Jun 01 2021 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
| Mar 08 2021 | ATHA | Athira Pharma, Inc ... | Kosacz Barbara | Director | Option Exercise | A | 19.29 | 27,742 | 535,143 | 27,742 | |
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | MOEBIUS HANS | Chief Medical Offic ... | Option Exercise | A | 21.15 | 72,000 | 1,522,800 | 72,000 | |
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | MILESON GLENNA | Chief Financial Off ... | Option Exercise | A | 21.15 | 73,500 | 1,554,525 | 73,500 | |
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | A | 21.15 | 85,000 | 1,797,750 | 85,000 | |
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | KAWAS LEEN | President & CEO | Option Exercise | A | 21.15 | 231,000 | 4,885,650 | 231,000 | |
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | CHURCH KEVIN | Vice President of D ... | Option Exercise | A | 21.15 | 20,000 | 423,000 | 20,000 | |
| Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | M | 1.35 | 3,783 | 5,107 | 0 | |
| Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | M | 1.19 | 25,220 | 30,012 | 0 | |
| Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | M | 1.35 | 3,783 | 5,107 | 143,884 | 140.1 K to 143.9 K (+2.70 %) |
| Feb 04 2021 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | M | 1.19 | 25,220 | 30,012 | 140,101 | 114.9 K to 140.1 K (+21.95 %) |
| Jan 27 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 22.50 | 311,111 | 6,999,998 | 3,425,916 | 3.1 M to 3.4 M (+9.99 %) |
| Dec 14 2020 | ATHA | Athira Pharma, Inc ... | Romano Kelly A | Director | Option Exercise | A | 29.41 | 27,742 | 815,892 | 27,742 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 | 2.1 M to 3.1 M (+51.50 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,644,785 | 0 | 2,055,981 | 411.2 K to 2.1 M (+400.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 | 2.1 M to 3.1 M (+51.50 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | EDELMAN JOSEPH | Director | Buy | C | 0.00 | 1,644,785 | 0 | 2,055,981 | 411.2 K to 2.1 M (+400.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 6,731 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 51,831 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Option Exercise | C | 0.00 | 12,610 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 6,731 | 0 | 6,731 | 0 to 6.7 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 51,831 | 0 | 114,881 | 63.1 K to 114.9 K (+82.21 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | FLUKE JOHN M JR | Director | Buy | C | 0.00 | 12,610 | 0 | 63,050 | 50.4 K to 63.1 K (+25.00 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 13,126 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 13,126 | 0 | 63,566 | 50.4 K to 63.6 K (+26.02 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Option Exercise | C | 0.00 | 1,535,131 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Buy | P | 17.00 | 750,000 | 12,750,000 | 2,668,913 | 1.9 M to 2.7 M (+39.08 %) |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | RTW INVESTMENTS, LP | 10% Owner | Buy | C | 0.00 | 1,535,131 | 0 | 1,918,913 | 383.8 K to 1.9 M (+400.00 %) |
Page: 1